$GNS

Genius Group (NYSE: GNS) targets ASX dual listing by Q4 2026

Genius Group Limited (NYSE: GNS) says it has received initial feedback from the ASX on its In Principle Advice Application for a planned dual listing. After filing its Form 20-F on March 9, 2026, the company expects to complete the ASX listing in Q4 2026, subject to ASX review and approval, according to the company.

Original reporting
Published Jul 29, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 10:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$GNS
Neutral
medium confidence
Mentioned
$GNS
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$GNSNeutralLow
01

Why it matters

The company reports initial ASX feedback and ongoing dialogue, reiterating an estimated completion and ASX listing in Q4 2026 subject to ASX review and approval.

02

Market read

This is a regulatory-process update that may affect expectations for future liquidity and investor access, but it does not provide an approval decision or financial impact details.

03

What to watch

Traders should monitor whether ASX feedback introduces additional requirements (governance, disclosure, free-float, or corporate structure) that could delay timing beyond Q4 2026, and whether the company plans any capital-raise tied to the listing.

Relevance 4/10Novelty 5/10Timing: process update on ASX dual listing, with target completion in Q4 2026

Background

Genius Group is a foreign private issuer that filed a Form 20-F and lodged an In Principle Advice Application with ASX via DLA Piper as part of a planned dual listing.

Company-level read

Ticker impact

$GNSNeutralMedium confidence
Context

Genius Group says it received initial feedback from ASX on its In Principle Advice Application for an ASX dual listing, targeting Q4 2026 subject to approval.

Expected impact

Near-term impact likely modest unless ASX feedback implies approval odds or timeline acceleration; watch for subsequent ASX acceptance milestones.

Evidence & confidence

The article discloses a new regulatory milestone (initial ASX feedback) and a reiterated target (Q4 2026), but provides no approval decision, conditions, or financial terms that would directly re-rate fundamentals immediately.

Market effects

Limited sector read-across; dual-listing mechanics are company-specific and do not signal a broader regulatory shift.

Potential incremental demand/liquidity in Australia if the listing proceeds, but no immediate market-wide effect is indicated.

Mostly local to US-Australia cross-listing flows; no global macro or capital-market disruption described.

Counterpoint

The disclosed milestone may not change approval probability materially; without ASX acceptance or specific conditions, the market may already be pricing the general possibility of an ASX listing.

Key entities

  • Genius Group Limited

    US-listed issuer (GNS) seeking an ASX dual listing and reporting initial ASX feedback on its application.

  • Australian Securities Exchange (ASX)

    Exchange providing initial feedback on the dual listing application and conducting the review/approval process.

  • DLA Piper

    Advisor involved in lodging the In Principle Advice Application and preparing the company’s response.

Related articles

$RMMed

RM and Genus: Markets live

RM (RM.) reported a 200% rise in half-year adjusted operating profit to £2.7mn despite revenue from continuing operations falling 4.2% to £70mn. The company cited restructuring and higher-margin assessment revenue, while UK education budgets and Middle East conflict weighed on tech and school supplies. Genus (GNS) said FY profit beat expectations, helped by PIC, and raised adjusted PBT guidance to £98mn vs £95.5mn consensus.

$GNSMedAI 8/10

Why is Genus stock surging today? By Investing.com

Investing.com reports Genus shares rose 5.8% to 2151p after the company issued a positive end-of-year trading update. Genus expects FY26 adjusted profit before tax of about £98m, above analyst expectations, citing stronger second-half performance, growth in PIC and ABS divisions, and strong cash conversion. UK’s FTSE 100 was near flat amid US-Iran tensions.

$GNSMed

Genus stock gains on upbeat FY26 outlook, strong cash flow By Investing.com

Genus plc (LSE:GNS) shares rose 3.2% after the company forecast FY26 adjusted profit before tax of about £98m, ahead of consensus £95.5m. It cited stronger H2 trading, PIC growth in Asia and Latin America, ABS double-digit profit growth, and strong cash conversion boosting FY26 free cash flow. Q4 included ~£111m net cash from Beijing Capital Agribusiness; net leverage to ~0.4x.

$GNSMed

Bronstein, Gewirtz & Grossman LLC Urges Genius Group Limited Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC said it filed a securities class action against Genius Group Limited (NYSE: GNS) and certain officers, alleging federal securities-law violations from April 12, 2022 to May 30, 2025. The complaint claims “spoofing” and deceptive orders allegedly distorted GNS pricing and bid-ask spreads. Investors may seek lead-plaintiff status by Aug. 28, 2026.

$GNSMed

Genius Group Buys Back 6,037,851 Company Shares

Genius Group (NYSE American: GNS) said it bought back 6,037,851 Class A ordinary shares in a privately negotiated off-market deal and will cancel them, following earlier buybacks. Combined with a 6.6 million share repurchase announced June 15, the company says 32.6 million shares were removed/reduced in 8 days, about 27% of public float.